ReviewReviews in cardiovascular medicine2024
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome.
Salvatore Giordano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it